Researchers have reported progress in the important effort to explain the rapid antidepressant action of ketamine, and in so doing, have gained insights that may inform the development of other ...
Regulators in the United States have recently approved a new prescription-only nasal spray for use against treatment-resistant depression. The FDA have approved a new medication for hard-to-treat ...
Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD). TRD is defined by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback